NCT07623408 Effect of Foot Position During Rehabilitation of Achilles Tendinopathy on Tendon Mechanics and Symptoms.
| NCT ID | NCT07623408 |
| Status | Recruiting |
| Phase | — |
| Sponsor | KU Leuven |
| Condition | Achilles Tendinopathy (AT) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-02-19 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-02-19 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will investigate whether a 12-week load-based exercise program performed with an externally rotated foot position ("toes-out") leads to different changes in intra-tendinous sliding, symptoms, and function compared to a standard exercise program performed with a neutral foot position in individuals with mid-portion Achilles tendinopathy. In addition, physical activity will be monitored during and after the intervention to examine how daily loading patterns relate to symptoms and functional recovery over a 6-month period.
Eligibility Criteria
The following inclusion criteria will be used: PATIENTS WITH ACHILLES TENDINOPATHY: * Voluntary written Informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures. * Age between 18 and 65 years old * BMI between 18.5-30 * Showing history of intermittent episodes of Achilles tendon pain lasting more than 3 consecutive weeks within the past 6 months. * Presenting palpable focal thickening of the Achilles tendon. * Having pain originating from the Achilles tendon on palpation of thickened tendon and on loading activities (such as running, jumping). * Showing sonographic evidence of tendinopathy, i.e. focal thickening and hypoechocity, consistent with previously reported sonographic characteristics diagnosed of tendinopathy. Prior to start of the data collection, these inclusion criteria (specifically the ones concerning Achilles Tendinopathy presence) will be checked by a medical doctor at SMAC (Sports medical advisory centre Leuven). Only if they confirm the diagnosis, patients are included in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07623408 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Achilles Tendinopathy (AT). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07623408 currently recruiting?
Yes, NCT07623408 is actively recruiting participants. Contact the research team at laura.lecompte@kuleuven.be for enrollment information.
Where is the NCT07623408 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT07623408 clinical trial?
NCT07623408 is sponsored by KU Leuven. The trial plans to enroll 60 participants.